Tags

Type your tag names separated by a space and hit enter

Kinetics of Serologic Responses to MERS Coronavirus Infection in Humans, South Korea.
Emerg Infect Dis. 2015 Dec; 21(12):2186-9.EI

Abstract

We investigated the kinetics of serologic responses to Middle East respiratory syndrome coronavirus (MERS-CoV) infection by using virus neutralization and MERS-CoV S1 IgG ELISA tests. In most patients, robust antibody responses developed by the third week of illness. Delayed antibody responses with the neutralization test were associated with more severe disease.

Authors

No affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't

Language

eng

PubMed ID

26583829

Citation

Park, Wan Beom, et al. "Kinetics of Serologic Responses to MERS Coronavirus Infection in Humans, South Korea." Emerging Infectious Diseases, vol. 21, no. 12, 2015, pp. 2186-9.
Park WB, Perera RA, Choe PG, et al. Kinetics of Serologic Responses to MERS Coronavirus Infection in Humans, South Korea. Emerg Infect Dis. 2015;21(12):2186-9.
Park, W. B., Perera, R. A., Choe, P. G., Lau, E. H., Choi, S. J., Chun, J. Y., Oh, H. S., Song, K. H., Bang, J. H., Kim, E. S., Kim, H. B., Park, S. W., Kim, N. J., Man Poon, L. L., Peiris, M., & Oh, M. D. (2015). Kinetics of Serologic Responses to MERS Coronavirus Infection in Humans, South Korea. Emerging Infectious Diseases, 21(12), 2186-9. https://doi.org/10.3201/eid2112.151421
Park WB, et al. Kinetics of Serologic Responses to MERS Coronavirus Infection in Humans, South Korea. Emerg Infect Dis. 2015;21(12):2186-9. PubMed PMID: 26583829.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Kinetics of Serologic Responses to MERS Coronavirus Infection in Humans, South Korea. AU - Park,Wan Beom, AU - Perera,Ranawaka A P M, AU - Choe,Pyoeng Gyun, AU - Lau,Eric H Y, AU - Choi,Seong Jin, AU - Chun,June Young, AU - Oh,Hong Sang, AU - Song,Kyoung-Ho, AU - Bang,Ji Hwan, AU - Kim,Eu Suk, AU - Kim,Hong Bin, AU - Park,Sang Won, AU - Kim,Nam Joong, AU - Man Poon,Leo Lit, AU - Peiris,Malik, AU - Oh,Myoung-Don, PY - 2015/11/20/entrez PY - 2015/11/20/pubmed PY - 2016/7/14/medline KW - MERS KW - MERS-CoV KW - Middle East respiratory syndrome KW - Middle East respiratory syndrome coronavirus KW - South Korea KW - antibody KW - clinical correlates KW - coronavirus KW - diagnostics KW - humans KW - immunity KW - kinetics KW - seroepidemiologic data KW - serologic responses KW - severity KW - viruses SP - 2186 EP - 9 JF - Emerging infectious diseases JO - Emerg Infect Dis VL - 21 IS - 12 N2 - We investigated the kinetics of serologic responses to Middle East respiratory syndrome coronavirus (MERS-CoV) infection by using virus neutralization and MERS-CoV S1 IgG ELISA tests. In most patients, robust antibody responses developed by the third week of illness. Delayed antibody responses with the neutralization test were associated with more severe disease. SN - 1080-6059 UR - https://www.unboundmedicine.com/medline/citation/26583829/Kinetics_of_Serologic_Responses_to_MERS_Coronavirus_Infection_in_Humans_South_Korea_ L2 - https://dx.doi.org/10.3201/eid2112.151421 DB - PRIME DP - Unbound Medicine ER -